Gene and Cell Therapy – News and Features

Future Medicine’s journal Nanomedicine has been selected for coverage in ISI® services after the publication of only five issues.

MBA Grupo will distribute the Cytori’s Celution™ System a medial device that removes a patient’s own stem and regenerative cells from their fat tissue.

With three human RNAi gene therapy trials now under way, the technique may be among the first to find widespread use for treating human diseases.

Celogos and Stem Cell Sciences KK have reached an agreement on the licensing of technologies for myoblast cell implantation for the treatment of stress urinary incontinence.

Copernicus Therapeutics will utilize the funds for the development its non-viral gene therapy for cystic fibrosis.

The collaboration will focus on development of a gene therapy capable of regulating mitochondrial fatty acid metabolism and insulin resistance.

Regenetech makes its licenses available to stem cell banks for its cellXpansion™ technology, which expands hematopoietic stem cells for autologous use.

University’s Coordinating Center for Clinical Trials receives $17.9 million grant to serve as the hub of a nationwide network to conduct the research on stem cell based treatments.

Aruna Biomedical signs licensing agreement with the University of Georgia to develop human neural progenitor cell technology developed at the University.

BioE and M. D. Anderson collaborate to determine the utility of Multi-Lineage Progenitor Cell™ as an anti-tumor protein delivery vehicle.